Affirm Holdings moves from Buy to Watchlist. Nothing went wrong with the business. The shares simply did what the last report expected, only faster, and the gap to fair value has closed too far for a new buyer.

What the old plan said

The 29 September report kept Affirm at Buy at $67.21. It set a staged entry between $66 and $72, a stop at $64 and a first target of $86, the probability-weighted fair value. Nine sessions later the stock closed at $80.70 on 9 October, up 20.1%. The stop was never close. The 9 October high of $81.09 came within about 6% of the first target, and most of the gain arrived in two sessions, 5.6% on 5 October and 4.6% on 9 October.

What actually changed

The company news was useful but small. Affirm signed a deal with Crate & Barrel on 29 September and, on 6 October, a partnership with Antom, the merchant payments arm of Ant International, that offers Affirm to Antom’s US merchants from October, with the UK to follow this year. It also set its first fiscal 2027 report for 5 November. None of these comes with a volume figure or changes the guidance.

The bigger shift was in rates. After September payrolls rose by only 29,000, futures pricing for a Fed increase at the late-October meeting fell from about 64% to roughly 16% to 18%. Short-end funding costs are the macro channel that hurts Affirm most directly, and the last two fair-value cuts were made for exactly that reason. The rally fits the change, though no single cause can be proven.

Why fair value stays at $86

The ten-year yield is still 5.22%, the Fed’s September minutes leaned toward another increase, and the first quarter carrying the higher funding costs has not been reported. Raising the value now would get ahead of the evidence. At $80.70, the stock trades near five times fiscal 2027 revenue, and the upside to $86 is 6.6%, well short of the 20% margin this coverage requires for a lender with Affirm’s funding and credit exposure. The bear-case value sits about 37% below the price.

What would bring the Buy back

Two routes. A pullback to about $71 restores a 21% gap and sits inside the earlier buy range. Alternatively, a 5 November report showing revenue less transaction costs holding near 4.16% of volume, with the new funding costs included, would justify a higher base case. The Fed’s 27-28 October decision is the other date to watch.

The scenario table, the recomputed levels and the full risk register are in the complete Affirm (AFRM) report on our Reports page.